AIM ImmunoTech AIM
NYSE AIM
$0.19 +0.01 (+6.19%)
As of: Oct 1, 2026 · 3:21 PM EDT

AIM ImmunoTech (AIM) Cash from Financing Activities (2010 - 2026)

Updated

AIM ImmunoTech (AIM) posted Cash from Financing Activities of $8.79 million for Q2 2026, compared with $355,000 a year earlier and up 57.3% from the prior quarter.

Analysis

AIM ImmunoTech (AIM) Cash from Financing Activities (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Cash from Financing Activities at AIM ImmunoTech was $23.75 million, up 984.8% year-over-year; for FY2025, it was $10.39 million, up 61.2% from FY2024.

  • Annual Cash from Financing Activities shows a five-year compound annual growth rate of -28.7% (FY2020 to FY2025).
  • In prior years, AIM ImmunoTech's Cash from Financing Activities was $6.44 million in FY2024, $485,000 in FY2023 (+506.3%), $80,000 in FY2022 (-99.0%) and $8.19 million in FY2021 (-85.5%).
  • The Q2 2026 figure stands as the highest quarterly Cash from Financing Activities since Q1 2021.
  • On a year-over-year basis, Cash from Financing Activities increased in three of the last six quarters, with growth averaging 218.5%.
  • The strongest year-over-year quarter for Cash from Financing Activities in the past five years was Q3 2023, with growth of 832.0%; the weakest was Q3 2021, with a decline of 99.8%.
  • According to Business Quant data, Cash from Financing Activities for the three prior quarters was $5.59 million (Q1 2026), $2.72 million (Q4 2025) and $6.65 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 AIM ImmunoTech 3.08 Mn -18.22 Mn 21,000.00 8.79 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.79 Mn
Mar 31, 2026 5.59 Mn
Dec 31, 2025 2.72 Mn
Sep 30, 2025 6.65 Mn
Jun 30, 2025 355,000.00
Mar 31, 2025 660,000.00
Dec 31, 2024 1.04 Mn
Sep 30, 2024 137,000.00
Jun 30, 2024 2.44 Mn
Mar 31, 2024 2.83 Mn
Dec 31, 2023 147,000.00
Sep 30, 2023 233,000.00
Jun 30, 2023 5,000.00
Mar 31, 2023 100,000.00
Sep 30, 2022 25,000.00
Dec 31, 2021 125,000.00
Sep 30, 2021 30,000.00
Jun 30, 2021 -4.76 Mn
Mar 31, 2021 12.79 Mn
Dec 31, 2020 3.04 Mn
API Access

AIM ImmunoTech Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=AIM&period=max&api_key=YOUR_API_KEY